• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

patterson fuse

















FUSE has returned to beta status based on customer feedback. Patterson felt it wasn't as ready as they had hoped and is currently working closely with offices who are participating in the beta to see where it needs to be improved. In theory, you can still sign up for their beta which is no cost for Fuse while it's in beta.
 
















Is normal to discount a product that's in beta or returns to beta. This is all pretty standard in software, people. They probably jumped the gun a bit going to general release but it's not that unusual
 
















you cant blame the new regime. Blame the left over 3 stooges from the Minnesota mafia regime. Can’t believe those losers are still stealing a paycheck

You can blame the newish regime. They've keep the dunderheads on. They're now just as culpable as the turds that were left behind by Anderson et al.
 












You are right! I stand corrected.

We’re all in sync on how useless we were under those deadbeats before and still are now.

Had hope that the cleaning house and ridding the place from the shitheads like Guggie, Killian and Rogen would have happened by now. They keep hovering around like the stooges they are. You’d think the newbies would have figured it out by now.